The MarketWatch News Department was not involved in the creation of this content.-- VYVGART(R) SC is first and only neonatal Fc receptor blocker approved to treat CIDP -- Authoriz ...
Topline phase 3 results show that the novel nanobody gefurulimab is safe and effective for AChR-antibody-positive myasthenia ...
Interesting Engineering on MSN
End of brain surgery? Injectable chips self-implant to treat brain disease safely
What if brain surgery could be replaced by a simple injection in the arm? MIT researchers may have found a way to make that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback